Press release
2022 Enasidenib Market Report- by Key Segments, Growth Size, Emerging Trends and Forecast | Celgene Corporation
Enasidenib Market report incorporates item types, market applications, geographic areas, and financial backers and providers. The overall statistical surveying gives a complete investigation of the business for the figure time frame. In addition, the examination incorporates a few divisions just as a full investigation of the market's patterns and critical determinants. Moreover, Enasidenib Market report assists you in overcoming the difficulties by applying various strategies.Download FREE PDF of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5456831
Enasidenib market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Enasidenib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- 50mg
- 100mg
Segment by Application
- Hospital
- Pharmacy
By Company
- Celgene Corporation
Get Discount on Purchase this Report @ https://www.reportsnreports.com/purchase.aspx?name=5456831
Table of Contents-
1 Study Coverage
1.1 Enasidenib Product Introduction
1.2 Market by Type
1.2.1 Global Enasidenib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 50mg
1.2.3 100mg
1.3 Market by Application
1.3.1 Global Enasidenib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Enasidenib Sales Estimates and Forecasts 2017-2028
2.2 Global Enasidenib Revenue Estimates and Forecasts 2017-2028
2.3 Global Enasidenib Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Enasidenib Sales by Region
2.4.1 Global Enasidenib Sales by Region (2017-2022)
2.4.2 Global Sales Enasidenib by Region (2023-2028)
2.5 Global Enasidenib Revenue by Region
2.5.1 Global Enasidenib Revenue by Region (2017-2022)
2.5.2 Global Enasidenib Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Enasidenib Sales by Manufacturers
3.1.1 Global Top Enasidenib Manufacturers by Sales (2017-2022)
3.1.2 Global Enasidenib Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Enasidenib in 2021
3.2 Global Enasidenib Revenue by Manufacturers
3.2.1 Global Enasidenib Revenue by Manufacturers (2017-2022)
3.2.2 Global Enasidenib Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Enasidenib Revenue in 2021
3.3 Global Enasidenib Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Enasidenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Enasidenib Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Enasidenib Sales by Type
4.1.1 Global Enasidenib Historical Sales by Type (2017-2022)
4.1.2 Global Enasidenib Forecasted Sales by Type (2023-2028)
4.1.3 Global Enasidenib Sales Market Share by Type (2017-2028)
4.2 Global Enasidenib Revenue by Type
4.2.1 Global Enasidenib Historical Revenue by Type (2017-2022)
4.2.2 Global Enasidenib Forecasted Revenue by Type (2023-2028)
4.2.3 Global Enasidenib Revenue Market Share by Type (2017-2028)
4.3 Global Enasidenib Price by Type
4.3.1 Global Enasidenib Price by Type (2017-2022)
4.3.2 Global Enasidenib Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Enasidenib Sales by Application
5.1.1 Global Enasidenib Historical Sales by Application (2017-2022)
5.1.2 Global Enasidenib Forecasted Sales by Application (2023-2028)
5.1.3 Global Enasidenib Sales Market Share by Application (2017-2028)
5.2 Global Enasidenib Revenue by Application
5.2.1 Global Enasidenib Historical Revenue by Application (2017-2022)
5.2.2 Global Enasidenib Forecasted Revenue by Application (2023-2028)
5.2.3 Global Enasidenib Revenue Market Share by Application (2017-2028)
5.3 Global Enasidenib Price by Application
5.3.1 Global Enasidenib Price by Application (2017-2022)
5.3.2 Global Enasidenib Price Forecast by Application (2023-2028)
6 North America
6.1 North America Enasidenib Market Size by Type
6.1.1 North America Enasidenib Sales by Type (2017-2028)
6.1.2 North America Enasidenib Revenue by Type (2017-2028)
6.2 North America Enasidenib Market Size by Application
6.2.1 North America Enasidenib Sales by Application (2017-2028)
6.2.2 North America Enasidenib Revenue by Application (2017-2028)
6.3 North America Enasidenib Market Size by Country
6.3.1 North America Enasidenib Sales by Country (2017-2028)
6.3.2 North America Enasidenib Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Enasidenib Market Size by Type
7.1.1 Europe Enasidenib Sales by Type (2017-2028)
7.1.2 Europe Enasidenib Revenue by Type (2017-2028)
7.2 Europe Enasidenib Market Size by Application
7.2.1 Europe Enasidenib Sales by Application (2017-2028)
7.2.2 Europe Enasidenib Revenue by Application (2017-2028)
7.3 Europe Enasidenib Market Size by Country
7.3.1 Europe Enasidenib Sales by Country (2017-2028)
7.3.2 Europe Enasidenib Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Enasidenib Market Size by Type
8.1.1 Asia Pacific Enasidenib Sales by Type (2017-2028)
8.1.2 Asia Pacific Enasidenib Revenue by Type (2017-2028)
8.2 Asia Pacific Enasidenib Market Size by Application
8.2.1 Asia Pacific Enasidenib Sales by Application (2017-2028)
8.2.2 Asia Pacific Enasidenib Revenue by Application (2017-2028)
8.3 Asia Pacific Enasidenib Market Size by Region
8.3.1 Asia Pacific Enasidenib Sales by Region (2017-2028)
8.3.2 Asia Pacific Enasidenib Revenue by Region (2017-2028)
and more..
+ 1 888 391 5441
sales@reportsandreports.com
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2022 Enasidenib Market Report- by Key Segments, Growth Size, Emerging Trends and Forecast | Celgene Corporation here
News-ID: 2567634 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Enasidenib
Enasidenib Market Development, Industry Trends, Demand and Growth Analysis and F …
The global Enasidenib market was valued at approximately USD 78 million in 2023 and is projected to reach USD 125.9 million by 2030, reflecting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/enasidenib-market
Enasidenib Market Overview:
The Enasidenib market is primarily driven by the increasing prevalence of acute myeloid leukemia (AML), specifically in patients with an IDH2 mutation. Enasidenib, a targeted…
Global Enasidenib Market Estimated to Experience a Hike in Growth by 2031
The global Enasidenib market was valued at approximately USD 87.9 million in 2023 and is projected to reach around USD 151.8 million by 2031, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.
Global Enasidenib Market Overview
The global enasidenib market is experiencing steady growth, driven by its effectiveness in treating relapsed or refractory acute myeloid leukemia (AML) with IDH2 mutations. In 2023, the market…
Enasidenib Market Analysis, Size, Current Scenario and Future Prospects
The Enasidenib Market is expected to register at a highest CAGR during the forecast period. Enasidenib is a drug that targets a gene mutation called IDH2 that affects the bone marrow. A mutation in the IDH2 gene inhibits young blood cells from maturing into healthy adult blood cells, resulting in acute myeloid leukaemia symptoms. Enasidenib Market research report allows making important decision making essential for business growth. It helps key…
Global Enasidenib Market, Size, Share, Analysis Report & Forecast to 2026
The Enasidenib Market is expected to register at a highest CAGR during the forecast period. Enasidenib is a drug that targets a gene mutation called IDH2 that affects the bone marrow. A mutation in the IDH2 gene inhibits young blood cells from maturing into healthy adult blood cells, resulting in acute myeloid leukaemia symptoms. AML is a form of blood cancer, that starts in the bone marrow and…
Global Enasidenib Drugs Market Report 2018-2025 | Segmantation by Industry Surve …
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
In 2018, the global Enasidenib Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the…
Global Enasidenib Market Report 2018: Top Manufacturers, Regions, Type and Appli …
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
In 2018, the global Enasidenib market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base…
